CONFERENCE COVERAGE SERIES
Society for Neuroscience Annual Meeting 2015
17 – 21 October 2015
Some 29,000 registrants descended on McCormick Place, the largest convention center in the United States, for the Society for Neuroscience annual meeting, held October 17-21 near downtown Chicago. Among the 18 symposia, 31 minisymposia, 98 nanosymposia, 650 poster sessions, and numerous special lectures was a shrinking but still lively fraction of Alzheimer’s science. Alzforum reporters Madolyn Rogers and Tom Fagan ferreted it out.
Snapshots from the Society for Neuroscience Annual Meeting
Basic science inspires conference goers in Chicago.
Microglia Control Synapse Number in Multiple Disease States
Research presented at SfN strengthens the case that microglia gorge on synapses in some neurodegenerative and neurodevelopmental disorders.
Might Normalizing Brain Development Help in Down’s Syndrome?
Researchers at SfN 2015 outlined perinatal treatments that rescued cognition in mouse models of the disease.
Potential Parkinson’s Treatments Target α-Synuclein, Cell Replacement
Two drugs that boost α-synuclein clearance have passed Phase 1 safety benchmarks, and a stem cell strategy is poised to enter trials, reported scientists at SfN 2015.
Alzheimer’s Risk Genes Give Up Some Secrets at SfN
Scientists start to unravel role played by genetic risk variants.
Alzheimer’s GWAS Hits Point to Endosomes, Synapses
Scientists at SfN offer alternate views of Bin1 biology.
Can Common Genetic Variation in Mice Nail Genes of Aging, Alzheimer’s?
Forget transgenics for a moment. Large collections of inbred and outbred mice could be an untapped treasure trove for Alzheimer’s researchers.
Preclinical Research Offers New Angles on Immunotherapy
Researchers at this year’s SfN meeting detailed different strategies and outcomes of passive and active vaccines.
Traumatic Brain Injury—Focus on Heterogeneity, Secondary Damage
In various animal models of traumatic brain injury, acute treatments quiet inflammation and preserve neurons and their myelin sheaths.